Fluorescein dye disappearance test in patients with different degrees of epiphora
dc.contributor.author | Toprak A.B. | |
dc.contributor.author | Erkin E.F. | |
dc.contributor.author | Kayikçioǧlu Ö. | |
dc.contributor.author | Seymenoǧlu G. | |
dc.contributor.author | Güler C. | |
dc.contributor.author | Unlu H.H. | |
dc.date.accessioned | 2024-07-22T08:25:11Z | |
dc.date.available | 2024-07-22T08:25:11Z | |
dc.date.issued | 2002 | |
dc.description.abstract | PURPOSE. To assess the diagnostic efficacy of a modification of the fluorescein dye disappearance test (DDT) in patients with different degrees of epiphora. METHODS. DDT was performed by instilling a drop of 2% fluorescein in the eye. Schirmer tear test strips were placed in the lower conjunctival fornix, after 3 and 10 minutes. The colour dilution on the strips was compared to a scale with known standards and the most closely comparable colour dilution was chosen and recorded as the visual scale test (VST) grade of the strip. The grey-scale value (GV) of each strip was calculated by computer image analysis. The control group comprised 44 patients, mean age 44.8 years (SD 7.5, range 30-60). There were 13 patients in group 1 with moderate epiphora; mean age was 44.2 years (SD 9.5, range 30-60). There were 17 patients in group 2 with severe epiphora; mean age was 48.3 years (SD 7.7, range 37- 60). RESULTS. VST and GV differed significantly between controls and group 1 patients at 3 minutes (p=0.002, p=0.001), and between controls and group 2 patients at 3 minutes (p<0.001, p<0.001). There was no difference between groups 1 and 2 patients in VST and GV at 3 minutes. The differences were highly significant between controls and group 1 at 10 minutes (p=0.001, p=0.007), and between controls and group 2 at 10 minutes (p<0.001, p<0.001). The differences in GV and VST between groups 1 and 2 were significant at 10 minutes (p=0.026, p=0.018). CONCLUSIONS. This modified DDT permits identification of different degrees of epiphora in a non-invasive manner, it can therefore be used to evaluate the outcome of different treatment strategies. | |
dc.identifier.DOI-ID | 10.1177/112067210201200503 | |
dc.identifier.issn | 11206721 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20302 | |
dc.language.iso | English | |
dc.publisher | Wichtig Editore s.r.l. | |
dc.subject | fluorescein | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | calculation | |
dc.subject | clinical article | |
dc.subject | color | |
dc.subject | computer analysis | |
dc.subject | controlled study | |
dc.subject | correlation analysis | |
dc.subject | diagnostic accuracy | |
dc.subject | disease classification | |
dc.subject | disease severity | |
dc.subject | epiphora | |
dc.subject | human | |
dc.subject | indicator dilution curve | |
dc.subject | intermethod comparison | |
dc.subject | outcomes research | |
dc.subject | priority journal | |
dc.subject | Schirmer test | |
dc.subject | statistical significance | |
dc.subject | time | |
dc.title | Fluorescein dye disappearance test in patients with different degrees of epiphora | |
dc.type | Article |